Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

EphA2-to-YAP pathway drives gastric cancer growth and therapy resistance.

Changhao Huang | Weijie Yuan | Chen Lai | Shangwei Zhong | Chen Yang | Ran Wang | Linfeng Mao | Zihua Chen | Zhikang Chen
International journal of cancer | 2020

Yes-associated protein (YAP) is a transcriptional coactivator that promotes cell proliferation, stem cell maintenance and tissue homeostasis. The YAP activity is primarily regulated through an inhibitory phosphorylation by the serine/threonine kinases of Hippo pathway. Here, we show that receptor tyrosine kinase (RTK) erythropoietin-producing hepatocellular receptor A2 (EphA2) interacts with and phosphorylates YAP protein, leading to stabilization, nuclear translocation and activation of YAP in gastric cancer (GC) cells. EphA2 induces chemotherapy-resistance by increasing YAP stability and nuclear YAP protein. Knockdown of YAP blocks EphA2-induced tumor growth in GC xenograft mouse models. Importantly, the coactivation of EphA2 and YAP is manifested in clinical human GC, and is related to GC recurrence. Thus, our results establish a novel EphA2-to-YAP pathway that drives GC growth, progression and therapy-resistance, targeting this pathway would be an efficient way for the treatment of GC, particularly chemotherapy-resistant GC.

Pubmed ID: 31376289

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


YAP (D8H1X) XP Rabbit mAb (antibody)

RRID:AB_2650491

This recombinant monoclonal targets YAP

View all literature mentions

Phospho-EphA2 (Ser897) (D9A1) Rabbit mAb (antibody)

RRID:AB_11220420

This monoclonal targets Phospho-EphA2 (Ser897) (D9A1) Rabbit mAb

View all literature mentions

HA-Tag (C29F4) Rabbit mAb (antibody)

RRID:AB_1549585

This monoclonal targets HA-Tag

View all literature mentions

EphA2 (D4A2) XP Rabbit mAb (antibody)

RRID:AB_10827743

This monoclonal targets EphA2 (D4A2) XP Rabbit mAb

View all literature mentions

KATO III (cell line)

RRID:CVCL_0371

Cell line KATO III is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

NCI-N87 (cell line)

RRID:CVCL_1603

Cell line NCI-N87 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

AGS (cell line)

RRID:CVCL_0139

Cell line AGS is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions